The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management

Abstract

Neuropsychiatric disorders denote a broad range of illnesses involving neurology and psychiatry. These disorders include depressive disorders, anxiety, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorders, headaches, and epilepsy. In addition to their main neuropathology that lies in the central nervous system (CNS), lately, studies have highlighted the role of immunity and neuroinflammation in neuropsychiatric disorders. Toll‐like receptors (TLRs) are innate receptors that act as a bridge between the innate and adaptive immune systems via adaptor proteins (e.g., MYD88) and downstream elements; TLRs are classified into 13 families that are involved in normal function and illnesses of the CNS. TLRs expression affects the course of neuropsychiatric disorders, and is influenced during their pharmacotherapy; For example, the expression of multiple TLRs is normalized during the major depressive disorder pharmacotherapy. Here, the role of TLRs in neuroimmunology, treatment, and management of neuropsychiatric disorders is discussed. We recommend longitudinal studies to comparatively assess the cell‐type‐specific expression of TLRs during treatment, illness progression, and remission. Also, further research should explore molecular insights into TLRs regulation and related pathways.

Network-Based Analysis Identifies Targetable Pathways in Comorbid Type II Diabetes and Neuropsychiatric Disorders

“…Evidence from preclinical models suggests that impaired mTOR signaling contributes to insulin resistance and β-cell dysfunction in DM2 and affects synaptic plasticity and neurogenesis in NPDs (63,(65)(66)(67)(68). Chronic inflammation is a common feature in DM2 and has been increasingly recognized in the pathology of NPDs, including the possible role of Toll-like receptor signaling in contributing to this inflammation (69)(70)(71). The identification of immune-related pathways suggests that inflammatory processes may be a shared mechanism contributing to the comorbidity.…”

Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment

“…Neuropsychiatric disorders encompass a wide spectrum of conditions at the intersection of neurology and psychiatry. These include depressive disorders, anxiety, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, headaches, and epilepsy ( Saleki et al, 2024 ). In addition to genetic factors and environmental stress, various diseases can contribute to the development of neuropsychiatric disorders, although the severity and clinical presentations may vary.…”

Editorial: Neuroimmune cell signaling in COVID-19

“…When immune system Toll-like receptors (TLRs) are exposed to SARS-CoV2 viral RNA and protein elements, hyperinflammation develops in multiple organs, including the lungs and CNS ( 7 , 8 ). Uncontrolled hyperinflammation in COVID-19 patients leads to a dysregulated immune response in the body leading to multi-organ neuroimmunological injury ( 9 – 11 ).…”